Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 9—September 2014
Research

Passive Surveillance for Azole-Resistant Aspergillus fumigatus, United States, 2011–2013

Cau D. PhamComments to Author , Errol Reiss, Ferry Hagen, Jacques F. Meis, and Shawn R. Lockhart
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (C.D. Pham, E. Reiss, S.R. Lockhart); Canisius Wilhelmina Hospital, Nijmegen, the Netherlands (F. Hagen, J.F. Meis); Radboud University Medical Centre, Nijmegen (F. Hagen, J.F. Meis)

Main Article

Figure 2

Itraconazole susceptibility profile for Aspergillus fumigatus isolates, United States, 2011–2013. The MIC (μg/mL) required by each isolate was determined by using the Etest method. Approximately 5% of the isolates require an MIC higher than the established epidemiologic cutoff value of 1 μg/mL.

Figure 2. Itraconazole susceptibility profile for Aspergillus fumigatus isolates, United States, 2011–2013. The MIC (μg/mL) required by each isolate was determined by using the Etest method. Approximately 5% of the isolates require an MIC higher than the established epidemiologic cutoff value of 1 μg/mL.

Main Article

Page created: August 13, 2014
Page updated: August 13, 2014
Page reviewed: August 13, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external